01 October 2008 By:
Dave Bormett
|
The potent nature of HPAPIs means there must be careful evaluation of the compound for its level of toxicity when considering manufacture.

01 September 2008 By:
Abraham Woldu, Weiyong Li, Denita Winstead
|
Near-infrared spectroscopy (NIR) is suitable for the analysis of pharmaceutical samples in various solid forms, and can be used for determining chemical properties (e.g., content of drug, water), as well as physical properties (e.g., particle size, tablet hardness).

01 May 2008 By:
Kamla Jevons, David Johnson
|
The pharmaceutical industry must address the release of nonbiodegradable APIs into the environment.

01 December 2007 By:
Susruta Majumdar, Kenneth B. Sloan
|
The permeation of drugs through the skin is compromised by the presence of polar functional groups such as thiols, alcohols, phenols, imides or amides. By transiently masking these polar functional groups as prodrugs the permeability of drugs containing these functional groups through the skin can be improved.

01 December 2007 By:
Eliana B. Souto, Rainer H. Müller, Antonio J. Alemieda
|
Lipid-based drug delivery systems — such as liposomes, micro-and nanoemulsions, self-emulsified drug delivery systems, and solid lipid micro-and nanoparticles — are becoming more popular because lipid materials are easily characterized, contain a high range of well-defined/tolerated surfactant molecules and can be developed for several administration routes.

01 November 2007 By:
Detlef Beckers, I. Lehrach, K-J. Steffens
|
The crystalline structure of pharmaceutical solids can sometimes be altered during processing. X-ray powder diffraction and near infrared spectroscopy can be used to determine the amorphous and crystalline content of a model substance. The two techniques' precision, accuracy, detection limit and the speed of analysis are compared.
